Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
申请人:Lutz Robert J.
公开号:US20120282282A1
公开(公告)日:2012-11-08
The invention relates to charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of using the same to reduce ocular toxicity associated with administration of antibody drug conjugates.
Charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of making the same.